Search Results - "Hadler, Stephen C."

Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination by Liang, Xiaofeng, Bi, Shengli, Yang, Weizhong, Wang, Longde, Cui, Gang, Cui, Fuqiang, Zhang, Yong, Liu, Jianhua, Gong, Xiaohong, Chen, Yuansheng, Wang, Fuzhen, Zheng, Hui, Wang, Feng, Guo, Jing, Jia, Zhiyuan, Ma, Jingchen, Wang, Huaqing, Luo, Huiming, Li, Li, Jin, Shuigao, Hadler, Stephen C, Wang, Yu

“…Abstract Objective To determine the prevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core anti-body…”
Get full text

Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in China by Liang, Xiaofeng , Bi, Shengli , Yang, Weizhong , Wang, Longde , Cui, Gang , Cui, Fuqiang , Zhang, Yong , Liu, Jianhua , Gong, Xiaohong , Chen, Yuansheng , Wang, Fuzhen , Zheng, Hui , Wang, Feng , Guo, Jing , Jia, Zhiyuan , Ma, Jingchen , Wang, Huaqing , Luo, Huiming , Li, Li , Jin, Shuigao , Hadler, Stephen C. , Wang, Yu 

“…Background. Endemic hepatitis B virus (HBV) infection is a serious health problem in China. Hepatitis B vaccination of infants was introduced in 1992 and was…”
Get full text

A mathematical model to estimate global hepatitis B disease burden and vaccination impact by Goldstein, Susan T, Zhou, Fangjun, Hadler, Stephen C, Bell, Beth P, Mast, Eric E, Margolis, Harold S

“…Background Limited data are available regarding global hepatitis B virus (HBV)-related morbidity and mortality and potential reduction in disease burden from…”
Get full text

A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012 by Xie, Yihong, Tan, Yi, Chongsuvivatwong, Virasakdi, Wu, Xinghua, Bi, Fuyin, Hadler, Stephen C, Jiraphongsa, Chuleeporn, Sornsrivichai, Vorasith, Lin, Mei, Quan, Yi

“…Acute meningitis and encephalitis (AME) are common diseases with the main pathogens being viruses and bacteria. As specific treatments are different, it is…”
Get full text

Population-based surveillance for bacterial meningitis in China, September 2006-December 2009 by Li, Yixing, Yin, Zundong, Shao, Zhujun, Li, Manshi, Liang, Xiaofeng, Sandhu, Hardeep S, Hadler, Stephen C, Li, Junhong, Sun, Yinqi, Li, Jing, Zou, Wenjing, Lin, Mei, Zuo, Shuyan, Mayer, Leonard W, Novak, Ryan T, Zhu, Bingqing, Xu, Li, Luo, Huiming

“…During September 2006-December 2009, we conducted active population and sentinel laboratory-based surveillance for bacterial meningitis pathogens, including…”
Get full text

Hepatitis A surveillance and vaccine use in China from 1990 through 2007 by Cui, Fuqiang, Hadler, Stephen C, Zheng, Hui, Wang, Fuzhen, Zhenhua, Wu, Yuansheng, Hu, Gong, Xiaohong, Chen, Yuansheng, Liang, Xiaofeng

“…Hepatitis A vaccines have been highly effective in preventing hepatitis A. To investigate the epidemiology of hepatitis A in China after hepatitis A vaccine…”
Get full text

Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments – New tools and approaches by Hadler, Stephen C., Shefer, Abigail M., Cavallaro, Kathleen F., Ebama, Malembe, Tencza, Catherine, Kennedy, Erin D., Ndiaye, Sidy, Shah, Adeel, Torre, Lisandro, Bresee, Joseph S.

“…•New tools are available to support NITAGs to develop evidence-based vaccine recommendations.•Facilitated trainings using the Evidence to recommendations (EtR)…”
Get full text

Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) – Experience from the Eastern Mediterranean Region of the World Health Organization, 2023 by Sume, Gerald Etapelong, Hasan, Quamrul, Shefer, Abigail, Henaff, Louise, Cavallaro, Kathleen F., Tencza, Catherine B., Hadler, Stephen C., Sidy, Ndiaye, Sardar, Parwiz, Kagina, Benjamin M., Hutin, Yvan

“…•NMAT is a comprehensive and user-friendly tool NITAGs, and secretariat can use with little or no external support.•Most countries had either a basic or…”
Get full text

Reprint of: Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination by Liang, Xiaofeng, Bi, Shengli, Yang, Weizhong, Wang, Longde, Cui, Gang, Cui, Fuqiang, Zhang, Yong, Liu, Jianhua, Gong, Xiaohong, Chen, Yuansheng, Wang, Fuzhen, Zheng, Hui, Wang, Feng, Guo, Jing, Jia, Zhiyuan, Ma, Jingchen, Wang, Huaqing, Luo, Huiming, Li, Li, Jin, Shuigao, Hadler, Stephen C, Wang, Yu

“…Abstract Objective To determine the prevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core anti-body…”
Get full text

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021 by Gargano, Julia W, Wallace, Megan, Hadler, Stephen C, Langley, Gayle, Su, John R, Oster, Matthew E, Broder, Karen R, Gee, Julianne, Weintraub, Eric, Shimabukuro, Tom, Scobie, Heather M, Moulia, Danielle, Markowitz, Lauri E, Wharton, Melinda, McNally, Veronica V, Romero, José R, Talbot, H Keipp, Lee, Grace M, Daley, Matthew F, Oliver, Sara E

“…In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the…”
Get full text

Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996–2018 by Otshudiema, John O, Acosta, Anna M, Cassiday, Pamela K, Hadler, Stephen C, Hariri, Susan, Tiwari, Tejpratap S P

“…Abstract Background Respiratory diphtheria is a toxin-mediated disease caused by Corynebacterium diphtheriae. Diphtheria-like illness, clinically…”
Get full text

The Brighton collaboration standardized module for vaccine benefit-risk assessment by Levitan, Bennett, Hadler, Stephen C., Hurst, William, Izurieta, Hector S., Smith, Emily R., Baker, Nicole L., Bauchau, Vincent, Chandler, Rebecca, Chen, Robert T., Craig, Danielle, King, Jay, Pitisuttithum, Punnee, Strauss, Walter, Tomczyk, Sylvie, Zafack, Joseline, Kochhar, Sonali

“…Vaccine Benefit-Risk (B-R) assessment consists of evaluating the benefits and risks of a vaccine and making a judgment whether the expected key benefits…”
Get full text

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States by Wallace, Megan, Rosenblum, Hannah G., Moulia, Danielle L., Broder, Karen R., Shimabukuro, Tom T., Taylor, Christopher A., Havers, Fiona P., Meyer, Sarah A., Dooling, Kathleen, Oliver, Sara E., Hadler, Stephen C., Gargano, Julia W.

“…To inform Advisory Committee for Immunization Practices (ACIP) COVID-19 vaccine policy decisions, we developed a benefit-risk assessment framework that…”
Get full text

Pertussis control: time for something new? by Clark, Thomas A, Messonnier, Nancy E, Hadler, Stephen C

“…Childhood acellular pertussis vaccines were licensed and implemented in the US in the 1990s following an effort to improve on the safety profile of whole-cell…”
Get full text

Ancillary benefits of seasonal influenza vaccination in middle-income countries by Ebama, Malembe S., Chu, Susan Y., Azziz-Baumgartner, Eduardo, Lafond, Kathryn E., McCarron, Margaret, Hadler, Stephen C., Porter, Rachael M., McKinlay, Mark, Bresee, Joseph

“…While seasonal influenza vaccines (SIV) remain the best method to prevent influenza-associated illnesses, implementing SIV programs may benefit countries…”
Get full text

The impact of hepatitis B vaccine in China and in the China GAVI Project by Hadler, Stephen C, Fuqiang, Cui, Averhoff, Francisco, Taylor, Thomas, Fuzhen, Wang, Li, Li, Xiaofeng, Liang, Weizhong, Yang

“…Highlights • The China GAVI Project (CGP) achieved 90% HB vaccine coverage in infants in CGP areas. • Between 1992 and 2009, HB vaccination prevented 24…”
Get full text

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021 by MacNeil, Jessica R, Su, John R, Broder, Karen R, Guh, Alice Y, Gargano, Julia W, Wallace, Megan, Hadler, Stephen C, Scobie, Heather M, Blain, Amy E, Moulia, Danielle, Daley, Matthew F, McNally, Veronica V, Romero, José R, Talbot, H Keipp, Lee, Grace M, Bell, Beth P, Oliver, Sara E

“…On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine…”
Get full text

Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations by Duintjer Tebbens, Radboud J., Pallansch, Mark A., Cochi, Stephen L., Ehrhardt, Derek T., Farag, Noha H., Hadler, Stephen C., Hampton, Lee M., Martinez, Maureen, Wassilak, Steve G.F., Thompson, Kimberly M.

“…Due to security, access, and programmatic challenges in areas of Pakistan and Afghanistan, both countries continue to sustain indigenous wild poliovirus (WPV)…”
Get full text

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021 by Rosenblum, Hannah G, Hadler, Stephen C, Moulia, Danielle, Shimabukuro, Tom T, Su, John R, Tepper, Naomi K, Ess, Kevin C, Woo, Emily Jane, Mba-Jonas, Adamma, Alimchandani, Meghna, Nair, Narayan, Klein, Nicola P, Hanson, Kayla E, Markowitz, Lauri E, Wharton, Melinda, McNally, Veronica V, Romero, José R, Talbot, H Keipp, Lee, Grace M, Daley, Matthew F, Mbaeyi, Sarah A, Oliver, Sara E

“…In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna COVID-19 vaccines, and in…”
Get full text

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021 by Oliver, Sara E, Gargano, Julia W, Scobie, Heather, Wallace, Megan, Hadler, Stephen C, Leung, Jessica, Blain, Amy E, McClung, Nancy, Campos-Outcalt, Doug, Morgan, Rebecca L, Mbaeyi, Sarah, MacNeil, Jessica, Romero, José R, Talbot, H Keipp, Lee, Grace M, Bell, Beth P, Dooling, Kathleen

“…What is already known about this topic? On February 27, 2021, the Food and Drug Administration issued an Emergency Use Authorization (EUA) for the Janssen…”
Get full text